Alx Oncology Holdings (ALXO) Profit After Tax (2019 - 2026)

Alx Oncology Holdings has disclosed Profit After Tax across 8 years of filings, most recently posting -$17.9 million for Q1 2026.

• Profit After Tax for Q1 2026 came in at -$17.9 million, up 41.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$88.9 million (up 31.65% YoY), and the FY2025 annual result was -$101.7 million, up 24.59% from the prior year.
• Profit After Tax came in at -$17.9 million for Q1 2026 at Alx Oncology Holdings, up from -$22.8 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$17.9 million in Q1 2026 to a low of -$51.0 million in Q3 2023.
• The 5-year median for Profit After Tax is -$30.7 million (2022), against an average of -$31.7 million.
• Across the five-year window, Profit After Tax tumbled 102.29% in 2022 and jumped 41.71% in 2026, its largest moves.
• Alx Oncology Holdings' Profit After Tax stood at -$30.7 million in 2022, then slumped by 48.07% to -$45.5 million in 2023, then jumped by 35.87% to -$29.2 million in 2024, then gained by 21.65% to -$22.8 million in 2025, then rose by 21.54% to -$17.9 million in 2026.
• The last three Profit After Tax figures came in at -$17.9 million (Q1 2026), -$22.8 million (Q4 2025), and -$22.1 million (Q3 2025), per Business Quant data.